David Tran

Chief, Associate Professor & Co-Director - Neuro-Oncology, Neurological Surgery & Neurology University of Southern California

Seminars

Thursday 19th February 2026
Panel Discussion – Leveraging Advanced Liquid Biopsies as a Next Generation Diagnostic Technique for GBM Assessments
3:00 pm
  • Discussing the limitations of traditional liquid biopsies using ctDNA for GBM monitoring
  • Exploring innovative techniques to capture and analyse circulating tumour cells from blood or CSF samples
  • Assessing the clinical utility liquid biopsies for GBMs to inform active genetic mutations and methylation status for treatment guidance
Tuesday 17th February 2026
Harnessing Omics Data & Molecular Subtyping to Inform Patient Stratification in Clinical & Translational Strategies in Glioblastoma Drug Development
8:00 am
  • Join this workshop to deepen your understanding of how omics approaches and molecular subtyping are used to stratify glioblastoma patients and define target populations for new therapies
  • Examining the strategic integration of multi-omics including genomics, transcriptomics, proteomics and epigenomics for a more comprehensive and clinically actionable GBM classification system
  • Identifying and validating specific molecular features as robust markers for defining GBM subtypes with prognostic and predictive value
  • Leveraging molecular subtyping further down the line in development to design biomarker-driven clinical trials to enrich patient experience and improve trial efficiency
  • Identifying and validating novel biomarkers with a focus on their identification in discovery
  • Looking towards personalized GBM treatment where therapy selection is guided by a patient’s molecular profile
David Tran, speaking at 7th Glioblastoma Drug Development Summit